Blisto 1MF Tablet PR
By Blisto MF
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg)

Manufacturer - Biocon
20th KM, Hosur Road, Electronic City, Bangalore, India - 560 100

Expires on or after
June, 2026

liver
When it comes to the use of Blisto 1MF Tablet PR, caution is advised for individuals with liver disease. It may be necessary to adjust the dosage of Blisto 1MF Tablet PR in such cases, so it is crucial to consult with your doctor before starting the medication. Typically, Blisto 1MF Tablet PR is initiated at a low dose for patients with mild to moderate liver disease. However, it is not recommended for use in individuals with severe liver disease. It is important to follow your healthcare provider's guidance closely to ensure safe and effective use of this medication.

kidney
Blisto 1MF Tablet PR should be used carefully in patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Regular kidney function tests are recommended during treatment. Consult your doctor for guidance.

alcohol
It is not safe to mix alcohol with Blisto 1MF Tablet PR.

driving
If you experience symptoms of low or high blood sugar, avoid driving while taking Blisto 1MF Tablet PR to ensure safety.

pregnancy
Blisto 1MF Tablet PR may be unsafe during pregnancy. Limited human studies suggest risks to the developing baby. Consult your doctor for a careful assessment of benefits and risks before using this medication.

breastfeeding
Caution Blisto 1MF Tablet PR is not safe to use while breastfeeding as it may cause toxicity to the baby.
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹165
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024